The Latin America GLP-1 agonists market size for pens still dwarfs tablets, but oral formats will increasingly attract first-line therapy seekers who dislike injections
New potent inhibitors of tyrosinase: novel clues to binding of 1,3,4-thiadiazole-2(3H)-thiones, 1,3,4-oxadiazole-2(3H)-thiones, 4-amino-1,2,4-triazole-5(4H)-thiones and substituted hydrazides to the dicopper active site
This article examines the evidence for using Wegovy and levothyroxine together, practical administration guidance, and when to seek medical advice
Last reviewed: June 6, 2026 Last updated: June 6, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations